Skip to main content

Sonnet BioTherapeutics Holdings, Inc.

SONNDelisted Dec 2, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001106838

Sonnet BioTherapeutics Holdings, Inc. was delisted on Dec 2, 2025; its insiders filed their last Form 4 on Dec 4, 2025; 27 institutions reported holding it in 13F filings for Q3 2025, worth $3.53M in total; no superinvestor held it.

13F holders, Q1 2026

Institutional positions in Sonnet BioTherapeutics Holdings, Inc. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

SONN is no longer listed, and 13F filings after Q3 2025 list far fewer holders. See Q3 2025

Institutional holders
0
−1 vs. Q4 2025
Shares held
0
−37.2K (−100.0%) vs. Q4 2025
Total value
$0
−$170.3K (−100.0%) vs. Q4 2025
New holders
0
0 more added
Sold out
1
0 more reduced

Compare with Q4 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting SONN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2026: 0 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 10 institutionsQ4 2023: 10 institutionsQ1 2024: 10 institutionsQ2 2024: 11 institutionsQ3 2024: 3 institutionsQ4 2024: 9 institutionsQ1 2025: 8 institutionsQ2 2025: 9 institutionsQ3 2025: 27 institutionsQ4 2025: 1 institutionQ1 2026: 0 institutionsQ2 2026: 0 institutions
Value heldQ1 2026: $0
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $110.1KQ4 2023: $157.8KQ1 2024: $117.6KQ2 2024: $550.0KQ3 2024: $2.97KQ4 2024: $130.2KQ1 2025: $216.1KQ2 2025: $223.7KQ3 2025: $3.53MQ4 2025: $170.3KQ1 2026: $0Q2 2026: $0
Institutions holding SONN and their total value by quarter
QuarterHoldersValue
Q2 20260$0
Q1 20260$0
Q4 20251$170.3K
Q3 202527$3.53M
Q2 20259$223.7K
Q1 20258$216.1K
Q4 20249$130.2K
Q3 20243$2.97K
Q2 202411$550.0K
Q1 202410$117.6K
Q4 202310$157.8K
Q3 202310$110.1K
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q1 2026

Shares, value and share of portfolio for each institution holding Sonnet BioTherapeutics Holdings, Inc.; share changes are against Q4 2025.

Institutions holding SONN in Q1 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Formidable Asset Management, LLC0$00.00%−37,185−100.0%Sold out